Tag #Pharmaceutical Litigation

Showing 1 to 7 of 7 results

lemonde.fr

🌐 85% Global Worthiness

May 10, 07:10

BMS and Sanofi Pay $700 Million to Settle Plavix Lawsuit

Bristol Myers Squibb and three Sanofi subsidiaries will pay $700 million to Hawaii to settle a decade-long lawsuit alleging they withheld information about Plavix's limited effectiveness, particularly for approximately 30% of patients, including a significant portion of Hawaii's population.

BMS and Sanofi Pay $700 Million to Settle Plavix Lawsuit

Bristol Myers Squibb and three Sanofi subsidiaries will pay $700 million to Hawaii to settle a decade-long lawsuit alleging they withheld information about Plavix's limited effectiveness, particularly for approximately 30% of patients, including a significant portion of Hawaii's population.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How did the limitations of Plavix disproportionately affect specific populations, and what role did this play in the lawsuit's outcome?

Hawaii's lawsuit against BMS and Sanofi centered on claims that studies showed Plavix's ineffectiveness in about 30% of patients, disproportionately affecting those of Asian and Pacific Islander descent. The $700 million settlement, equally shared by both companies, follows a previous court ruling that found the companies deliberately hampered research into Plavix's limitations. This highlights the significant financial consequences of failing to fully disclose drug efficacy information.

edition.cnn.com

🌐 85% Global Worthiness

Dec 20, 04:10

DOJ Sues CVS for Allegedly Filling Illegal Opioid Prescriptions

The US Department of Justice sued CVS on Wednesday for allegedly filling illegal opioid prescriptions from 2013 onward, violating the Controlled Substances Act, ignoring red flags, and contributing to patient deaths; this follows a $5 billion settlement with state and local governments in 2022 but r...

DOJ Sues CVS for Allegedly Filling Illegal Opioid Prescriptions

The US Department of Justice sued CVS on Wednesday for allegedly filling illegal opioid prescriptions from 2013 onward, violating the Controlled Substances Act, ignoring red flags, and contributing to patient deaths; this follows a $5 billion settlement with state and local governments in 2022 but r...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How did CVS's internal practices and performance metrics contribute to the alleged violations of the Controlled Substances Act, and what role did company culture play?

CVS's alleged actions, driven by profit-focused performance metrics, ignored internal warnings and led to the filling of prescriptions from known "pill mills." The lawsuit details instances where patients died after filling prescriptions at CVS pharmacies, highlighting a systemic failure to prioritize patient safety. This case underscores the broader opioid crisis and the role of pharmacies in contributing to it.

apnews.com

🌐 85% Global Worthiness

Dec 11, 04:10

Ohio Supreme Court Overturns $650 Million Opioid Judgment Against Pharmacies

The Ohio Supreme Court overturned a $650 million judgment against CVS, Walgreens, and Walmart in an opioid lawsuit brought by Lake and Trumbull counties, ruling that state law prohibits such public nuisance claims against pharmaceutical companies, potentially impacting similar cases nationwide.

Ohio Supreme Court Overturns $650 Million Opioid Judgment Against Pharmacies

The Ohio Supreme Court overturned a $650 million judgment against CVS, Walgreens, and Walmart in an opioid lawsuit brought by Lake and Trumbull counties, ruling that state law prohibits such public nuisance claims against pharmaceutical companies, potentially impacting similar cases nationwide.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of the Ohio Supreme Court's decision on the $650 million judgment against CVS, Walgreens, and Walmart in the opioid crisis litigation?

The Ohio Supreme Court overturned a $650 million judgment against CVS, Walgreens, and Walmart, ruling that Ohio's product liability law prohibits counties from suing pharmaceutical chains for public nuisance related to the opioid crisis. This decision is based on the court's interpretation of the Ohio Product Liability Act (OPLA), which they say prevents all common law product liability claims, even those seeking equitable relief. The ruling impacts Lake and Trumbull counties, who had initially won the lawsuit.

abcnews.go.com

🌐 85% Global Worthiness

Dec 11, 07:11

Ohio Supreme Court Overturns $650 Million Opioid Judgment

The Ohio Supreme Court overturned a $650 million judgment against CVS, Walgreens, and Walmart in an opioid lawsuit, ruling that state law prohibits counties from using public nuisance claims against pharmaceutical companies; this decision could impact billions in opioid settlements nationwide.

Ohio Supreme Court Overturns $650 Million Opioid Judgment

The Ohio Supreme Court overturned a $650 million judgment against CVS, Walgreens, and Walmart in an opioid lawsuit, ruling that state law prohibits counties from using public nuisance claims against pharmaceutical companies; this decision could impact billions in opioid settlements nationwide.

Progress

32% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of the Ohio Supreme Court's decision on opioid litigation?

The Ohio Supreme Court overturned a $650 million judgment against CVS, Walgreens, and Walmart, ruling that state product liability law prohibits counties from using public nuisance claims against pharmaceutical companies in opioid litigation. This decision impacts ongoing opioid lawsuits nationwide, potentially affecting billions of dollars in settlements. The ruling significantly limits the legal avenues available to local governments seeking to hold pharmaceutical companies accountable for the opioid crisis.

us.cnn.com

🌐 85% Global Worthiness

Jan 23, 10:08

Kennedy to Retain Financial Stake in Pharma Litigation Despite HHS Nomination

President Trump's nominee for Health and Human Services Secretary, Robert F. Kennedy Jr., will retain financial interests in pharmaceutical litigation, including a 10% contingency fee in cases against Merck regarding Gardasil, even while overseeing drug policy, raising ethical concerns.

Kennedy to Retain Financial Stake in Pharma Litigation Despite HHS Nomination

President Trump's nominee for Health and Human Services Secretary, Robert F. Kennedy Jr., will retain financial interests in pharmaceutical litigation, including a 10% contingency fee in cases against Merck regarding Gardasil, even while overseeing drug policy, raising ethical concerns.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What long-term consequences might result from Kennedy's potential confirmation, considering his financial interests and previous public statements regarding vaccine safety?

This situation raises concerns about potential bias and conflicts of interest. Kennedy's continued financial stake in litigation against pharmaceutical companies, particularly concerning vaccines, could influence his policy decisions. His confirmation hearings will be crucial in addressing these ethical concerns.

abcnews.go.com

🌐 85% Global Worthiness

Dec 11, 01:09

Ohio Supreme Court Overturns $650 Million Opioid Judgment

The Ohio Supreme Court overturned a $650 million judgment against CVS, Walgreens, and Walmart in an opioid lawsuit, ruling that state law prohibits counties from using public nuisance claims against pharmaceutical companies; this decision could impact similar cases nationwide.

Ohio Supreme Court Overturns $650 Million Opioid Judgment

The Ohio Supreme Court overturned a $650 million judgment against CVS, Walgreens, and Walmart in an opioid lawsuit, ruling that state law prohibits counties from using public nuisance claims against pharmaceutical companies; this decision could impact similar cases nationwide.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the impact of the Ohio Supreme Court's decision on the $650 million judgment against national pharmacies in the opioid litigation?

The Ohio Supreme Court overturned a $650 million judgment against CVS, Walgreens, and Walmart, ruling that state product liability law prohibits counties from using public nuisance claims against pharmaceutical companies in opioid litigation. This decision could significantly impact similar cases nationwide, potentially jeopardizing billions in settlements already reached. The court's interpretation of the Ohio Product Liability Act (OPLA) prevents product-liability claims seeking equitable relief, even if they don't involve compensatory damages.

abcnews.go.com

🌐 85% Global Worthiness

Dec 11, 04:11

Ohio Supreme Court Overturns $650 Million Opioid Judgment

The Ohio Supreme Court overturned a $650 million judgment against CVS, Walgreens, and Walmart in an opioid lawsuit, ruling that state law prohibits counties from using public nuisance claims against pharmaceutical companies; this decision may affect similar cases nationwide.

Ohio Supreme Court Overturns $650 Million Opioid Judgment

The Ohio Supreme Court overturned a $650 million judgment against CVS, Walgreens, and Walmart in an opioid lawsuit, ruling that state law prohibits counties from using public nuisance claims against pharmaceutical companies; this decision may affect similar cases nationwide.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the impact of the Ohio Supreme Court's decision on opioid litigation nationwide?

The Ohio Supreme Court overturned a $650 million judgment against CVS, Walgreens, and Walmart, ruling that state product liability law prohibits counties from using public nuisance claims against pharmaceutical companies in opioid litigation. This decision could impact similar cases nationwide, potentially hindering efforts to hold corporations accountable for their role in the opioid crisis. The ruling was largely unanimous, with only two justices dissenting.

Showing 1 to 7 of 7 results